Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 05 May 2022 10:20 CEST |
NAVAMEDIC | Navamedic ASA acquires Impolin AB and broadens obesity portfolio | 20103015 Pharmaceuticals | Inside information |
| 29 Apr 2022 08:01 CEST |
NAVAMEDIC | Navamedic: Annual report 2021 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 17 Feb 2022 08:00 CET |
NAVAMEDIC | Navamedic ASA: Resultater for fjerde kvartal 2021 | 20103015 Pharmaceuticals | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 17 Feb 2022 08:00 CET |
NAVAMEDIC | Navamedic ASA: Q4 2021 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Feb 2022 16:40 CET |
NAVAMEDIC | Navamedic ASA launches SmectaGO[®] - an innovative on-the-go product for treatment of diarrhea | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 14 Feb 2022 14:30 CET |
NAVAMEDIC | Navamedic ASA: Invitation to 2021 Fourth quarter presentation | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Dec 2021 13:35 CET |
NAVAMEDIC | Navamedic ASA: Trading Update | 20103015 Pharmaceuticals | Inside information |
| 06 Dec 2021 15:25 CET |
NAVAMEDIC | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |